To: (1) Establish a state-operated reinsurance program; (2) require the state to apply for a state innovation waiver to fund such program; (3) require the Office of Health Strategy to consider and adjust for any unintended effects or impacts of primary care spending targets on funding for those with developmental disabilities when benchmarking; (4) require the Office of Health Strategy to institute a program for prescription drug benchmarking; and (5) establish a task force to study the impact of spread pricing with prescription drugs and the savings or potential savings under current and alternative programs for the pooling of purchasing of prescription drugs.